列线图预测低危前列腺癌男性根治性前列腺切除术后的不良病理结局
本研究为单中心回顾性分析,纳入426例接受根治性前列腺切除术的低危前列腺癌男性,构建预测不良病理结局(Gleason评分升级或非器官局限性疾病)的列线图,并在另一医院103例男性中进行外部验证。列线图曲线下面积为87%,验证队列中预测概率与实际发生率一致;有无不良病理结局患者的5年生化复发无生存率分别为98%和70%。
要点
- 列线图预测低危前列腺癌根治性前列腺切除术后不良病理结局的曲线下面积为87%。
- 外部验证队列中列线图预测概率与实际不良病理结局发生率一致。
- 有无不良病理结局患者的5年生化复发无生存率分别为98%和70%。
核心结论
- 这种新型列线图有助于识别有不良病理结局风险的低危前列腺癌男性,并可能与治疗决策相关。
研究设计与样本
- 单中心回顾性分析,纳入426例接受根治性前列腺切除术的低危前列腺癌男性作为开发队列。
- 验证队列包括来自另一家医院的103例男性。
- 不良病理结局定义为根治性前列腺切除术Gleason评分升级(从GS 3+3升至GS≥3+4且Gleason模式4≥10%)或非器官局限性疾病(病理分期≥pT3a)。
- 采用多变量逻辑回归分析构建预测不良病理结局的列线图。
- 通过计算受试者工作特征曲线下面积(AUC)并在外部队列中比较列线图预测概率与实际不良病理结局发生率来进行验证。
主要发现
- 开发队列426例男性中,45.7%在根治性前列腺切除术中显示不良病理结局。
- 多变量分析中,年龄、体重指数、前列腺特异性抗原密度、既往阴性活检史、磁共振成像前列腺影像报告和数据系统评分4-5以及阳性活检百分比为显著预测因素。
- 构建的列线图曲线下面积为87%。
- 验证队列中列线图预测概率与实际不良病理结局发生率之间一致。
- 有无不良病理结局患者的5年生化复发无生存率分别为98%和70%。
临床怎么用
- 作者认为这种新型列线图有助于识别有不良病理结局风险的低危前列腺癌男性,并可能与治疗决策相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To develop and validate a prediction model to predict the risk of adverse pathology outcome on final pathology in low-risk prostate cancer (PCa) men. MATERIALS AND METHODS: This study was a monocentric retrospective analysis of 426 men who underwent radical prostatectomy (RP) for low-risk PCa. The validation cohort included 103 men from another hospital. Adverse pathology outcome was defined either by upgrading on RP Gleason Score (GS) (from GS 3+3 to GS ≥ 3+4 with Gleason pattern 4 ≥ 10%) or a non-organ confined disease (pathologic stage ≥ pT3a). Multivariable logistic regression analysis was performed to build nomogram for predicting adverse pathology outcome. Nomogram validation was performed by calculating the area under receiver operating characteristic curves (AUC) and comparing nomogram-predicted probabilities with actual rates of adverse pathology outcome in the external cohort. The Kaplan-Meier method was used to estimate and compare the biochemical recurrence-free survival rates between the two groups. RESULTS: Of 426 men in the development cohort, 45.7% showed adverse pathology outcome on RP. Age, body mass index, prostate specific antigen density, history of prior negative biopsy, magnetic resonance imaging prostate imaging reporting and data system score 4-5 and percentage of positive biopsies were significant predictors in multivariate analysis. A nomogram was constructed with an area under curve of 87%. There was agreement between predicted and actual rates of adverse pathology outcome in the validation cohort. The 5-year biochemical recurrence-free survival rates in patients with and without adverse pathology outcome was 70% and 98%, respectively. CONCLUSION: This novel nomogram would help identify low-risk PCa men at risk of adverse pathology outcome and can be relevant for treatment decision-making.
引用
- Nasri J, Barthe F, Parekh S, et al. Nomogram Predicting Adverse Pathology Outcome on Radical Prostatectomy in Low-Risk Prostate Cancer Men. Urology. 2022. PMID: 35263642. doi:10.1016/j.urology.2022.02.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。